Neurotensin is a versatile modulator of in vitro human Pancreatic Ductal Adenocarcinoma Cell (PDAC) migration

Cellular Oncology

Volumn 29, Issue 4, 2007, Pages 315-326

  Mijatovic, Tatjana ^a   Gailly, Philippe ^b   Mathieu, Véronique ^a   De Nève, Nancy ^c   Yeaton, Paul ^d   Kiss, Robert ^a   Decaestecker, Christine ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c Unibioscreen SA   (Belgium)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Cell migration; Integrins; Neurotensin; Pancreatic cancer; Sortilin NTR3

Indexed keywords

GUANOSINE TRIPHOSPHATASE; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL MIGRATION; COMPUTER ANALYSIS; CONTROLLED STUDY; CYTOSKELETON; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MICROSCOPY; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ACTINS; CARCINOMA, PANCREATIC DUCTAL; CDC42 GTP-BINDING PROTEIN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETON; ENZYME ACTIVATION; HUMANS; INTEGRIN ALPHAV; INTEGRIN BETA CHAINS; MODELS, BIOLOGICAL; NEUROTENSIN; PROTEIN SUBUNITS; RAC1 GTP-BINDING PROTEIN; RECEPTORS, NEUROTENSIN; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; VITRONECTIN;

EID: 34447126386     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. M. Baumgart, E. Heinmoller, O. Horstmann, H. Becker and B.M. Ghadimi, The genetic basis of sporadic pancreatic cancer, Cell. Oncol. 27 (2005), 3-13.
2. N. Belot, S. Rorive, I. Doyen, F. Lefranc, E. Bruyneel, R. Dedecker, S. Micik, J. Brotchi, C. Decaestecker, I. Salmon, R. Kiss and I. Camby, Molecular characterization of cell substratum attachments in human glial tumors relate to prognostic features, Glia 36 (2001), 375-390.
3. M. Caceres, J. Guerrero and J. Martinez, Overexpression of RhoA-GTP induces activation of the Epidermal Growth Factor Receptor, dephosphorylation of focal adhesion kinase and increased motility in breast cancer cells, Exp. Cell. Res. 309 (2005), 229-238.
4. I. Camby, I. Salmon, E. Bourdel, N. Nagy, A. Danguy, J. Brotchi, J.L. Pasteels, J. Martinez and R. Kiss, Neurotensin-mediated effects on astro3cytic tumor cell proliferation, Neuropeptides 30 (1996), 133-139.
5. I. Castagliuolo, C.C. Wang, L. Valenick, A. Pasha, S. Nikulasson, R.E. Carraway and C. Pothoulakis, Neurotensin is a proinflammatory neuropeptides in colonic inflammation, J. Clin. Invest. 103 (1999), 843-849.
6. O. Debeir, P. Van Ham, R. Kiss and C. Decaestecker, Tracking of migrating cells under phase-contrast video microscopy with combined mean-shift processes, IEEE Trans. Med. Imaging 24 (2005), 697-711.
7. P. Friedl and K. Wolf, Tumour-cell invasion and migration: diversity and escape mechanisms, Nat. Rev. Cancer 3 (2003), 362-374.
8. P. Gailly and M. Colson-Van Schoor, Involvement of trp-2 protein in store operated influx of calcium in fibroblasts, Cell. Calcium 30 (2001), 157-165.
9. 2+ entry coupling" in fibroblasts expressing the rat neurotensin receptor, J. Physiol. 491 (1996), 635-646.
10. F.G. Giancotti and E. Ruoslahti, Integrin signaling, Science 285 (1999), 1028-1032.
11. D. Gully, M. Canton, R. Boigegrain, F. Jeanjean, J.C. Molimard, M. Poncelet, C. Gueudet, M. Heaulme, R. Leyris, A. Brouard et al., Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor, Proc. Natl. Acad. Sci. USA 90 (1993), 65-69.
12. Y. Hegerfeldt, M. Tusch, E.B. Bröcker and P. Friedl, Collective cell movement in primary melanoma explants: Plasticity of cell-cell interaction, β1-integrin function, and migration strategies, Cancer Res. 62 (2002), 2125-2130.
13. J.D. Hood, R. Frausto, W.B. Kiosses, M.A. Schwartz and D.A. Cheresh, Differential alphaV integrin-mediated Ras-ERK signaling during two pathways of angiogenesis, J. Cell. Biol. 162 (2003), 933-943.
14. A. Huttenlocher, R.R. Sandborg and A.F. Horwitz, Adhesion in cell migration, Curr. Opin. Cell. Biol. 7 (1995), 697-706.
15. M. Iijima, Y.E. Huang and P. Devreotes, Temporal and spatial regulation of chemotaxis, Dev. Cell. 3 (2002), 469-478.
16. J. Ishizuka, C.M. Townsend Jr. and J.C. Thompson, Neurotensin regulates growth of human pancreatic cancer, Ann. Surg. 217 (1993), 439-445.
17. K. Iwase, B.M. Evers, M.R. Hellmich, H.J. Kim, S. Higashide, D. Gully, J.C. Thompson and C.M. Townsend Jr., Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692, Cancer 79 (1997), 1787-1793.
18. S. Keleg, P. Büchler, R. Ludwig, M.W. Büchler and H. Friess, Invasion and metastasis in pancreatic cancer, Mol. Cancer 2 (2003), 1-7.
19. K. Kisfalvi, S. Guha and E. Rozengurt, Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling in ductal pancreatic cancer cells, J. Cell. Physiol. 202 (2005), 880-890.
20. P. Kitabgi, Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes, Curr. Opin. Drug Discov. Devel. 5 (2002), 764-776.
21. F. Lefranc, C. Decaestecker, J. Brotchi, C.W. Heizmann, O. Dewitte, R. Kiss and T. Mijatovic, Co-expression/co-location of S100 proteins (S100B, S100A1 and S100A2) and protein kinase C (PKC-beta, -eta and -zeta) in a rat model of cerebral basilar artery vasospasm, Neuropathol. Appl. Neurobiol. 31 (2005), 649-660.
22. F. Lefranc, T. Mijatovic, V. Mathieu, S. Rorive, C. Decaestecker, O. Debeir, J. Brotchi, P. Van Ham, I. Salmon and R. Kiss, Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells, Clin. Cancer Res. 10 (2004), 8250-8265.
23. Z. Li, C.D. Aizenman and H.T. Cline, Regulation of rho GTPases by crosstalk and neuronal activity in vivo, Neuron 33 (2002), 741-750.
24. S. Linder, E. Castanos-Velez, A. von Rosen and P. Biberfeld, Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma, Hepatogastroenterology 48 (2001), 1321-1327.
25. M. Löhr, B. Trautmann, M. Gottler, S. Peters, I. Zauner, B. Maillet and G. Kloppel, Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins, Br. J. Cancer 69 (1994), 144-151.
26. +-ATPase activity through high affinity peptide receptor, Peptides 21 (2000), 571-576.
27. M. Magazin, E. Poszepczynska-Guigne, M. Bagot, L. Boumsell, C. Pruvost, P. Chalon, J.M. Culouscou, P. Ferrara and A. Bensussan, Sezary syndrome cells unlike normal circulating T lymphocytes fail to migrate following engagement of NTR1 receptor, J. Invest. Dermatol. 122 (2004), 111-118.
28. M. Mareel and A. Leroy, Clinical, cellular, and molecular aspects of cancer invasion, Physiol. Rev. 83 (2003), 337-376.
29. S. Martin, V. Navarro, J.P. Vincent and J. Mazella, Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line, Gastroenterology 123 (2002), 1135-1143.
30. S. Martin, J.P. Vincent and J. Mazella, Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia, J. Neurosci. 23 (2003), 1198-1205.
31. V. Mathieu, T. Mijatovic, M. Van Damme and R. Kiss, Gastrin exerts pleiotropic effects on human melanoma cell biology, Neoplasia 7 (2005), 930-943.
32. A. Morinville, S. Martin, M. Lavallee, J.P. Vincent, A. Beaudet and J. Mazella, Internalization and trafficking of neurotensin via NTS3 receptors in HT29 cells, Int. J. Biochem. Cell. Biol. 36 (2004), 2153-2168.
33. V. Navarro, J.P. Vincent and J. Mazella, Shedding of the luminal domain of the neurotensin receptor-3/sortilin in the HT29 cell line, Biochem. Biophys. Res. Commun. 298 (2002), 760-764.
34. S.S. Ng, M.S. Tsao, S. Chow and D.W. Hedley, Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells, Cancer Res. 60 (2000), 5451-5455.
35. T.J. Park and K.T. Kim, Activation of B2 bradykinin receptors by neurotensin, Cell. Signal. 15 (2003), 519-527.
36. C.M. Petersen, M.S. Nielsen, C. Jacobsen, J. Tauris, L. Jacobsen, J. Gliemann, S.K. Moestrup and P. Madsen, Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding, EMBO J. 18 (1999), 595-604.
37. C.M. Petersen, M.S. Nielsen, A. Nykjaer, L. Jacobsen, N. Tommerup, H.H. Rasmussen, H. Roigaard, J. Gliemann, P. Madsen and S.K. Moestrup, Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography, J. Biol. Chem. 272 (1997), 3599-3605.
38. J.C. Reubi, B. Waser, H. Friess, M. Buchler and J. Laissue, Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma, Gut 42 (1998), 546-550.
39. J.C. Reubi, Peptide receptors as molecular targets for cancer diagnosis and therapy, Endocr. Rev. 24 (2003), 389-427.
40. N.M. Ryder, S. Guha, O.J. Hines, H.A. Reber and E. Rozengurt G, protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation, J. Cell. Physiol. 186 (2001), 53-64.
41. E.E. Sander, J.P. ten Klooster, S. van Delft, R.A. van der Kammen and J.G. Collard, Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior, J. Cell. Biol. 147 (1999), 1009-1022.
42. S. Servotte, I. Camby, O. Debeir, C. Deroanne, C.A. Lambert, C.M. Lapière, B. Nusgens and C. Decaestecker, The in vitro influences of neurotensin on the motility characteristics of human U373 glioblastoma cells, Neuropathol. Appl. Neurobiol. 32 (2006), 575-584.
43. S. Srinivasan, F. Wang, S. Glavas, A. Ott, F. Hofmann, K. Aktories, D. Kalman and H.R. Bourne, Rac and Cdc42 play distinct roles in regulating PI(3,4,5)P3 and polarity during neutrophil chemotaxis, J. Cell. Biol. 160 (2003), 375-385.
44. R.P. Thomas, M.R. Hellmich, C.M. Townsend and B.M. Evers, Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues, Endocr. Rev. 24 (2003), 571-599.
45. F. Wang, P. Herzmark, O.D. Weiner, S. Srinivasan, G. Servant and H.R. Bourne, Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils, Nat. Cell. Biol. 4 (2002), 513-518.
46. J. Wang, H. Friess, Z. Zhu, H. Graber, A. Zimmermann, M. Korc, J.C. Reubi and M.W. Buchler, Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease, Clin. Cancer. Res. 6 (2000), 566-571.
47. G.C. Zondag, E.E. Evers, J.P. ten Klooster, L. Janssen, R.A. van der Kammen and J.G. Collard, Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition, J. Cell. Biol. 149 (2000), 775-782.